Survival prediction in amyotrophic lateral sclerosis

1 October 1989

journal article
research article
Published by Wiley in Muscle & Nerve

Vol. 12 (10) , 833-841
https://doi.org/10.1002/mus.880121008

Abstract

This longitudinal study of 194 patients with sporadic ALS demonstrated that it is possible for physicians to predict the approximate survival time for an individual ALS patient given: (1) the age of the patient, (2) the duration of his weakness and (3) an estimate of his clinical disability (ALS Score). This information is of value in the clinical management of ALS patients, and it should facilitate construction of experimental therapeutic trials in ALS.

This publication has 13 references indexed in Scilit:

Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
Cancer, 2006
A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience
Annals of Neurology, 1987
Quantitative motor assessment in amyotrophic lateral sclerosis
Neurology, 1986
Transfer factor is ineffective in amyotrophic lateral sclerosis
Annals of Neurology, 1979
Spirometry in Amyotrophic Lateral Sclerosis
Archives of Neurology, 1979
Double‐blind study of modified neurotoxin in motor neuron disease
Neurology, 1979
Amyotrophic Lateral Sclerosis
Archives of Neurology, 1978
MOTOR NEURON DISEASE
Acta Neurologica Scandinavica, 1977
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
British Journal of Cancer, 1977
The administration of guanidine in amyotrophic lateral sclerosis
Neurology, 1974